Amanote Research
Register
Sign In
264. Translating RNAi Therapy for Spinocerebellar Ataxia 1 (SCA1) to the Clinic
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35277-7
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
Gene Therapies for Spinocerebellar Ataxia Type 1
Brain Derived Neurotrophic Factor (BDNF) Delays Onset of Pathogenesis in Transgenic Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1)
Frontiers in Cellular Neuroscience
Molecular Neuroscience
Cellular
Spinocerebellar Ataxia With Axonal Neuropathy Type 1
Rod-Cone Dystrophy in Spinocerebellar Ataxia Type 1
Archives of Ophthalmology
Spinocerebellar Ataxia Type 13
Spinocerebellar Ataxia Type 3
Spinocerebellar Ataxia Type 8
Spinocerebellar Ataxia Type 12
Spinocerebellar Ataxia Type 37